Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been confirmed by lab testing to have one of three types of cancer: prostate cancer (Cohort A), urothelial carcinoma — a cancer of the bladder or urinary tract (Cohort B), or renal cell carcinoma — a type of kidney cancer (Cohort C).
- People who are willing and able to sign and date a consent form agreeing to take part in the study.
- People who are willing to follow all study procedures and are available for the full duration of the study.
- People who are 18 years of age or older at the time of giving consent.
- People who are currently receiving a systemic (whole-body) cancer treatment and whose doctors plan for them to continue that same treatment, with no more than a 30-day pause to allow for a targeted local treatment.
- People who have already received at least one round of systemic treatment for cancer that has spread to other parts of the body, and whose most recent treatment has been working well for at least 3 months before new or growing spots appeared — meaning their doctor considers most of the cancer to be stable and not yet requiring a change in treatment.
- People who have 5 or fewer new or growing cancer spots in the body.
- People whose new or growing cancer spots can all be safely treated with targeted local therapies, as determined by the treating radiation oncologist and/or interventional radiologist.
Who may not be able to join:
- People whose other health conditions make targeted local treatments unsafe for them.
- People who have previously experienced side effects from prior treatments that would prevent or limit the safe use of targeted local treatments.
- People who have cancer spots in the brain that are currently growing.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mamta Parikh, MD, MS, University of California, Davis
Phone: 916-382-6970
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with controlled disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.